Qiagen NV
Diagnostics & Research
Healthcare
QGEN
220 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
45.64
52 week high
51.79
high
46.00
52 week low
0.00
low
45.55
growth
1.58 %
previous Close
45.73
P/E ratio
market cap
10.44 B
div yield
0
usd
Mar 2025
qoq
revenue
483 M
-7.24 %
net incoming
90.76 M
2.76 %
eps
0.00 %
-9.84 %
eps surprise
7.84 %
net profit margin
18.77 %
1.00 %
operating incoming
115 M
-3.15 %
net change in cash
-24.80 M
91.99 %
cash on hand
639 M
-3.74 %
cost of revenue
175 M
1.97 %
top top